MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539

Leland Rogers; Peixin Zhang; Michael Vogelbaum; Arie Perry; Lynn S Ashby; Jignesh Modi; Anthony Alleman; James Galvin; Shannon Fogh; Emad Youssef; Nimsha Deb; Young Kwok; Clifford G Robinson; Hui-Kuo Shu; Barbara J Fisher; Valerie Panet-Raymond; William McMillan; John de Groot; Minesh P Mehta

doi:10.1093/neuonc/nox168.546

MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539

Leland Rogers, Peixin Zhang, Michael Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh Modi, Anthony Alleman, James Galvin, Shannon Fogh, Emad Youssef, Nimsha Deb, Young Kwok, Clifford G Robinson, Hui-Kuo Shu, Barbara J Fisher, Valerie Panet-Raymond, William McMillan, John de Groot, Minesh P Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	19
DOIs	https://doi.org/10.1093/neuonc/nox168.546
State	Published - Nov 6 2017

Access to Document

10.1093/neuonc/nox168.546License: Unspecified

Cite this

Rogers, L., Zhang, P., Vogelbaum, M., Perry, A., Ashby, L. S., Modi, J., Alleman, A., Galvin, J., Fogh, S., Youssef, E., Deb, N., Kwok, Y., Robinson, C. G., Shu, H.-K., Fisher, B. J., Panet-Raymond, V., McMillan, W., de Groot, J., & Mehta, M. P. (2017). MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539. Neuro-oncology, 19. https://doi.org/10.1093/neuonc/nox168.546

@article{18bfb38d2a524de7a293fb2112c9147e,

title = "MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539",

author = "Leland Rogers and Peixin Zhang and Michael Vogelbaum and Arie Perry and Ashby, {Lynn S} and Jignesh Modi and Anthony Alleman and James Galvin and Shannon Fogh and Emad Youssef and Nimsha Deb and Young Kwok and Robinson, {Clifford G} and Hui-Kuo Shu and Fisher, {Barbara J} and Valerie Panet-Raymond and William McMillan and {de Groot}, John and Mehta, {Minesh P}",

note = "PURPOSE/OBJECTIVESInitial analysis of high-risk meningioma on NRG Oncology/RTOG-0539, outlining 3yPFS, overall survival (OS) and adverse events (AEs)MATERIALS/METHODSThis phII trial apportioned patients to 1 of 3 risk groups and management strategies by WHO grade, recurrence status, and resection extent. High-risk included newly diagnosed or recurrent WHOIII or recurrent WHOII of any resection extent, or newly diagnosed WHOII with subtotal resection (STR).",

year = "2017",

month = nov,

day = "6",

doi = "10.1093/neuonc/nox168.546",

language = "American English",

volume = "19",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539

AU - Rogers, Leland

AU - Zhang, Peixin

AU - Vogelbaum, Michael

AU - Perry, Arie

AU - Ashby, Lynn S

AU - Modi, Jignesh

AU - Alleman, Anthony

AU - Galvin, James

AU - Fogh, Shannon

AU - Youssef, Emad

AU - Deb, Nimsha

AU - Kwok, Young

AU - Robinson, Clifford G

AU - Shu, Hui-Kuo

AU - Fisher, Barbara J

AU - Panet-Raymond, Valerie

AU - McMillan, William

AU - de Groot, John

AU - Mehta, Minesh P

N1 - PURPOSE/OBJECTIVESInitial analysis of high-risk meningioma on NRG Oncology/RTOG-0539, outlining 3yPFS, overall survival (OS) and adverse events (AEs)MATERIALS/METHODSThis phII trial apportioned patients to 1 of 3 risk groups and management strategies by WHO grade, recurrence status, and resection extent. High-risk included newly diagnosed or recurrent WHOIII or recurrent WHOII of any resection extent, or newly diagnosed WHOII with subtotal resection (STR).

PY - 2017/11/6

Y1 - 2017/11/6

UR - http://academic.oup.com/neuro-oncology/article/19/suppl_6/vi133/4590717

U2 - 10.1093/neuonc/nox168.546

DO - 10.1093/neuonc/nox168.546

M3 - Article

VL - 19

JO - Neuro-oncology

JF - Neuro-oncology

ER -

MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539

Access to Document

Other files and links

Cite this